Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)Seeking Alpha • 05/20/24
Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)Seeking Alpha • 05/15/24
Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)Seeking Alpha • 05/14/24
INOVIO Reports First Quarter 2024 Financial Results and Recent Business HighlightsPRNewsWire • 05/13/24
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsPRNewsWire • 04/15/24
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn MedicinePRNewsWire • 03/26/24
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?Zacks Investment Research • 03/08/24
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsPRNewsWire • 03/06/24
Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should KnowZacks Investment Research • 02/21/24
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024PRNewsWire • 02/21/24
Inovio Pharmaceuticals, Inc. (INO) CEO Jacque Shea Presents at Oppenheimer 34th Annual Healthcare Life Sciences Conference TranscriptSeeking Alpha • 02/14/24
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferencePRNewsWire • 02/07/24
How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%Zacks Investment Research • 01/30/24
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion LeaderPRNewsWire • 01/22/24